Microsoft Azure customers worldwide can now access The Craneware Group's full portfolio of co-sell-ready Trisus® SaaS solutions, leveraging the scalability, reliability, and agility of Azure to accelerate application development and advance business strategy. The Craneware Group, a leader in healthcare performance optimization, today announced the availability of ten additional co-sell-ready Software as a Service (SaaS) […]

(Other OTC:CTGL),(OTC US:CTGL), Palm Beach, Florida, Oct. 24, 2025 (GLOBE NEWSWIRE) — ​Dear Shareholders, Investors, Partners and Friends,I am pleased to announce that we have begun a new era for SkyTech Orion Global Corp. – an era of innovation, strength, and growth, with a strategic vision to lead the next generation of unmanned systems and

Citrine Global Corp. (DBA SkyTech Orion Global Corp.) (OTCQB: CTGL) today issued a shareholder update letter from the Company's Chairwoman and Chief Executive Officer, Ora Elharar-Soffer GlobeNewswire October 24, 2025 Palm Beach, Florida, Oct. 24, 2025 (GLOBE NEWSWIRE) — ​Dear Shareholders, Investors, Partners and Friends,I am pleased to announce that we have begun a new

VANTAA, Finland, Oct. 24, 2025 (GLOBE NEWSWIRE) — Canatu has granted a commercial production license for the first CNT100 SEMI reactor to Korean semiconductor company FINE SEMITECH CORPORATION (hereinafter “FST”). The license authorizes FST as the licensee to mass-produce CNT pellicle membranes using the CNT100 SEMI reactor, which will be operated by FST. FST will

Canatu grants license for commercial production of CNT pellicle membranes using CNT100 SEMI reactor GlobeNewswire October 24, 2025 VANTAA, Finland, Oct. 24, 2025 (GLOBE NEWSWIRE) — Canatu has granted a commercial production license for the first CNT100 SEMI reactor to Korean semiconductor company FINE SEMITECH CORPORATION (hereinafter “FST”). The license authorizes FST as the licensee

Ortho Molecular Products, a leading nutraceutical manufacturer exclusively serving licensed health care practitioners, has partnered with New Zealand-based Calocurb® to bring Calocurb® CLINICAL to the professional channel. Through this agreement, Ortho Molecular Products holds exclusive rights to launch and distribute Calocurb® CLINICAL, a targeted, plant-based appetite and craving control supplement designed specifically for clinical use.

(NYSE MKT:MCRP), Completed Initial Public Offering (“IPO”) at $4.00 per share raising $15.5 million in gross proceeds, began trading on NYSE American on March 7, 2025, under ticker symbol “MCRP” Signs agreement to deliver Artificial Intelligence (“AI”) and robotics infrastructure for SEE Holding's Sustainable City 2.0 and commenced testing phase Showcased next-generation robotics portfolio at

Micropolis Announces Financial Results for the Six Months Ended June 30, 2025 and Provides Business Update GlobeNewswire October 24, 2025 Completed Initial Public Offering (“IPO”) at $4.00 per share raising $15.5 million in gross proceeds, began trading on NYSE American on March 7, 2025, under ticker symbol “MCRP” Signs agreement to deliver Artificial Intelligence (“AI”)

Eight monthly winners receive $2,500 scholarship to attend massage school of their choice Today, Massage Envy, a nation's leading provider of massage across its franchise network, and national leader in skin care, announced the winners of its August 2025 Massage Envy National Scholarship Sweepstakes for Massage Therapists. Since launching this initiative in 2022, Massage Envy

Levi & Korsinsky, LLP notifies investors in MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (NASDAQ: MLTX) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of MoonLake investors who were adversely affected by alleged securities fraud between March 10, 2024 and September 29, 2025. Follow the link below